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Background: No expert consensus guides practice for intensity of ongoing pediatric cardiology surveillance of
hemodynamically insignificant small and moderate muscular ventricular septal defect (mVSD). Therefore, despite the
well-established benign natural history of mVSD, there is potential for widely divergent follow up practices. The
purpose of this investigation was to evaluate (1) variations in follow up of mVSD within an academic children’s
hospital based pediatric cardiology practice, and (2) the frequency of active medical or surgical management
resulting from follow up of mVSD.
Methods: We retrospectively reviewed records of 600 patients with isolated mVSD echocardiographically
diagnosed between 2006 and 2012. Large mVSD were excluded (n = 4). Patient age, gender, echocardiographic
findings, provider, recommendations for follow up, and medical and surgical management were tabulated at initial
and follow up visits. Independent associations with follow up recommendations were sought using multivariate
analysis.
Results: Initial echocardiography showed small single mVSD in 509 (85%), multiple small mVSD in 60 (10%), and
small-to-moderate or moderate single mVSD in 31 (5%). The mean age at diagnosis was 15.9 months (0–18.5 years)
and 25.7 months (0–18.5 years) at last follow up. There was slight female predominance (56.3%). Fourteen pediatric
cardiology providers recommended 316 follow up visits, 259 of which were actually accomplished. There were 37
other unplanned follow up visits. No medical or surgical management changes were associated with any of the
follow up visits. The proportion of patients for whom follow up was advised varied among providers from 11 to
100%. Independent associations with recommendation for follow up were limited to the identity and clinical
volume of the provider, age of the patient, and the presence of multiple, small-to-moderate, or moderate mVSD.
Conclusions: In this large series of moderate or smaller mVSD, pediatric cardiology follow up was commonly
recommended but resulted in no active medical or surgical management. Major provider based inconsistency in
intensity of follow up of mVSD was identified, but is difficult to justify.
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Ventricular septal defect (VSD) is the most common iso-
lated congenital cardiac defect, representing up to 40%
of congenital cardiac defects diagnosed in infancy [1].
Defects located within the muscular septum constitute
the more frequently seen type of VSD [2]. The natural* Correspondence: skutty@unmc.edu
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unless otherwise stated.history of muscular ventricular septal defects (mVSD) is
well described. Up to 76% undergo spontaneous closure
by the end of the first year of life [3-7], a large propor-
tion of which close by six months of age [3,4,8]. The
rates of spontaneous closure are higher for mVSD com-
pared to membranous VSD [6,7]. In a series of apical
mVSD’s diagnosed between 1 day and 13 years of age,
up to 44% spontaneous closure rate was reported within
3 years of diagnosis [4]. A 1.8% risk of infective endocar-
ditis has been reported for VSD, mostly occurring in theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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endocarditis complication for isolated mVSDs in their
series [10]. The majority of small mVSD do not require
surgical management, and for those small defects that
remain patent, long-term complication rates are minimal
[9-12].
Despite the well-described natural history and benign
course, no expert consensus guides practice for intensity
of ongoing pediatric cardiology surveillance of small
mVSD. A survey by Smith and Qureshi demonstrates
the general divergence of opinion regarding follow up
for congenital heart defects [13]. Follow up practice pat-
terns of hemodynamically insignificant mVSD have not
been specifically studied previously. The purpose of this
investigation is to evaluate (1) variations in follow up of
mVSD within an academic children’s hospital based
group pediatric cardiology practice, and (2) the fre-
quency of active medical or surgical management result-
ing from follow up of mVSD.
Methods
This was a retrospective cohort study performed in a
university affiliated academic children’s hospital, in ac-
cordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments.
The Institutional Review Board of the University of
Nebraska Medical Center approved the study. Informed
consent was waived for subjects included. Pediatric car-
diology databases were used to identify patients who had
echocardiographic diagnosis of mVSD between 2006 and
2012.
In accordance with the recommended standards and
guidelines for pediatric echocardiography set by the In-
tersocietal Accreditation Commission for Echocardiog-
raphy Laboratories (ICAEL) and the American Society
of Echocardiography, echocardiography was performed
by registered cardiac sonographers, and reported by
board certified pediatric cardiologists. Only those pa-
tients who had hemodynamically insignificant mVSD on
echocardiography, evidenced by restrictive left to right
shunting, absence of ventricular hypertrophy, and nor-
mal pulmonary artery pressure were included. Patients
with age appropriate patent foramen ovale and patent
ductus arteriosus were also included. Specific exclusion
criteria consisted of (1) patients with additional VSD lo-
cated in areas besides the muscular septum, (2) patients
with any associated cardiac lesion, (3) patients with large
mVSD, and 4) patients with previous cardiothoracic
surgery.
Patient age, gender, echocardiographic findings, PC
provider, recommendations for follow up, and medical
and surgical management at initial and follow up visits
were obtained from medical records review. Patients
were categorized based on echocardiographic reportedsize of mVSD (small, small-to-moderate, moderate,
large) and number of mVSD (isolated or multiple) at ini-
tial diagnosis. Patient age was categorized as younger
(<3 months at entry into study) vs. older. Pediatric cardi-
ology providers were categorized based on training
(physician pediatric cardiologist vs. physician assistant),
on clinical volume during the study (≥50 cases vs. < 50
cases), and on echocardiographic expertise (official inter-
preter of echocardiograms vs. non-interpreter).
Follow-up
At initial visit and each subsequent follow up, pediatric
cardiology provider visit records were reviewed. The fol-
lowing information was obtained from the records for
each provider: (1) continued presence or spontaneous
closure of mVSD by clinical exam and by echocar-
diography, (2) if the mVSD remained open, provider im-
pression regarding hemodynamic effects of the defect
(significant or insignificant), (3) recommendation for fol-
low up, (4) time until next recommended follow up, and
(5) recommendation for medical or surgical management.
Statistics
Descriptive statistics for categorical variables are re-
ported as frequency and percentage. Univariate compa-
risons of outcome were made among dichotomous
variables using the Chi square test. Candidate independent
variables were selected based on univariate correlation
(p < 0.15), and were incorporated into a multivariate logis-
tic regression to generate a model associating them with
follow up recommendation. Alpha to enter and alpha to
exclude variables from the stepwise process were both
0.15. A p value of <0.05 represented significance. Statis-
tical analysis was performed with commercially available




After exclusion of 4 patients with large mVSD, the study
population consisted of 600 patients with mVSD. None
of the patients had a swiss cheese septum. There were
262 males (43.7%) and 338 females (56.3%). The mean
age at diagnosis was 15.9 months (0–18.5 years) and at
last follow up 25.7 months (0–18.5 years). Initial Echo
showed isolated small mVSD in 509 patients (85%), mul-
tiple small mVSD in 60 (10%), isolated small-to-
moderate mVSD in 12 (2%), and isolated moderate
mVSD in 19 (3%) patients (Table 1).
Follow-up patterns
In all, 316 follow up visits were recommended by four-
teen pediatric cardiology providers, of which 259 were
actually accomplished. There were 37 other unplanned
Table 1 Characteristics of muscular VSD and associated
rate of follow up recommendation
mVSD size Number of
patients
Rate of follow up
recommendation (%)
Isolated small 509 (85%) 32
Isolated small-to-moderate 12 (2%) 42
Isolated moderate 19 (3%) 84
Multiple small 60 (10%) 58
mVSD muscular ventricular septal defect.
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surgical management were made at any of the follow up
visits. The mean follow up duration was 1.4 years (range
1 month to 5 years). For those patients who were dis-
missed from follow up, the mean interval from initial
visit to dismissal was 0.82 years (range 0 days to
12.3 years). There were 12 MD (evaluated 85% of small
mVSDs) and 2 non-MD physician assistant providers
(evaluated 15% of small mVSDs).
Follow up was recommended for patients with an iso-
lated small mVSD at a rate of 32%, versus 68% for
small-to-moderate and moderate isolated mVSD, and
58% for multiple small mVSD (p < 0.001, Table 1). Youn-
ger age at first visit was associated with greater rate of
recommendation for follow up. The mean age at first
visit for patients who were recommended follow up was
11.4 months vs. 18.4 months for patients who were not
recommended follow up (p = 0.006).
There was significant variability in follow up recom-
mendations between providers, ranging from 11-100%
(Table 2). Independent associations with recommenda-









1 4 4 100
2 274 244 99
3 27 22 82
4 83 72 87
5 6 5 83
6 87 69 79
7 38 28 74
8 5 4 80
9 11 8 73
10 13 11 85
11 23 18 78
12 18 13 72
13 6 6 100
14 5 5 100
mVSD muscular ventricular septal defect.provider, the mVSD characteristics (multiple mVSD, iso-
lated small-to-moderate, or isolated moderate mVSD),
and patient age under 3 months at first visit (Table 3).
Patient gender, echo-reading provider, and non-MD pro-
vider did not appear to be independently related to sub-
specialty follow-up recommendations (Table 3).
Discussion
No clear consensus exists about the value of follow up
for small mVSD [14]. Of 52 respondents to a small sur-
vey conducted among pediatric cardiology providers in
the UK, the majority would follow up a hemodynamically
insignificant VSD in three years, 15% would do so in one
year, and less than 10% would dismiss the patient upon
diagnosis [13]. Our experience confirmed the striking
variability in actual practice that the survey would lead us
to expect. In this report, individual providers recom-
mended pediatric cardiology follow up for as few as 11%
and as many as 100% of their patients.
Small mVSD are common. Studies prior to the routine
use of echocardiography determined an incidence of 1.3-
3.3 VSD per 1000 live births [15,16], but with the advent
of echocardiography, incidence has increased signifi-
cantly [8,17,18]. Because the population of children with
small mVSD is large, a policy of routine pediatric cardi-
ology follow up would consume substantial resources in
the subspecialty outpatient clinic. The benefits of this in-
vestment are not obvious; given the natural history stud-
ies that show uncomplicated small mVSD carries a high
likelihood of spontaneous closure [3-7,11,12], and little
if any prospect for clinical deterioration [11,12]. It is im-
pressive that the provider with the largest practice hadder follow up practice patterns for small muscular VSD
ntage of patients
small mVSD
Number of follow up
recommendations
Percentage of patients
















Table 3 Independent associations with recommendation for follow up
Univariate analysis Multivariate analysis
Variable Nwith (% Follow-up recommended) Nwithout (% Follow-up recommended) p Odds ratio (95% CL) p
High volume provider 444 (26.3) 156 (66.0) <0.001 5.23 (3.44-7.93) <0.001
Non MD provider 88 (31.8) 512 (37.5) 0.303 —————— ———
Echo reader provider 451 (33.7) 149 (45.6) 0.009 1.20 (0.78-1.84) 0.409
Male gender 262 (36.3) 338 (37.0) 0.855 —————— ———
Multiple mVSD 60 (58.3) 540 (34.3) <0.001 0.38 (0.21-0.68) 0.001
Small-moderate or
moderate mVSD
31 (67.7) 569 (35.0) <0.001 0.27 (0.12-0.63) 0.002
Age < 3 months 304 (44.1) 296 (29.0) <0.001 0.57 (0.39-0.83) 0.003
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the smaller clinical practice had the higher rates. This
would suggest that provider experience might be associ-
ated with better resource utilization, perhaps driven by
greater confidence.
Our data confirms that among a large number of
pediatric cardiology follow up visits for mVSD, we could
identify no case in which it resulted in active medical or
surgical management of the condition. Certain clinical
features, such as younger age of the patient, number of
defects, and any suggestion that the defect may be moder-
ate size, appeared to influence the likelihood that follow
up would be arranged without identifying a subgroup in
which active medical or surgical management actually
took place. Patients with multiple small mVSD in this
series were recommended follow up more often than iso-
lated small mVSD. Patients with isolated moderate sized
mVSD were recommended follow up at a greater rate than
those with isolated small-to-moderate and small sized de-
fects. We speculate that perceived differences in spontan-
eous closure rates (between defects of different sizes and
numbers) might have influenced follow up recommenda-
tions. It is known that age at diagnosis and method of
diagnosis influence reported spontaneous closure rates
for VSD [3,6,7,19,20]. Young age at diagnosis was a sig-
nificant predictor of spontaneous closure [19,21].
Even after accounting for age of the patient and per-
ceived size and number of muscular VSD’s, we found
that follow-up recommendations are highly provider
dependent. We interpret this as a sign that follow up
recommendations for mVSD in our series were not
evidence-based. Recently, the implementation of standard-
ized clinical assessment management plans (SCAMPS)
methodology reduced resource use and practice variation
in the outpatient evaluation of pediatric cardiology chest
pain [22]. A similar process could be applied to establish
care standards for subspecialty surveillance of small
mVSD.
Living in a society that presumes that more healthcare
is better healthcare, and supposing that any cardiacdefect represents a threat, concerned parents may exert
pressure on pediatric cardiologists to provide ongoing
subspecialty care for small mVSD. No physical harm
likely arises from asking these patients to return for sub-
specialty follow-up, but because there were no interven-
tions for those in this series who did return, it is
intriguing to speculate whether harm of other sorts
might be done. Pediatric cardiologists have long been
sensitive to concerns that if benign conditions are
permitted to be understood as threats, that inappropriate
restrictions might be imposed on the patients by well-
meaning parents, other care providers, or school
personnel [23]. It is beyond the scope of this investiga-
tion to decide if diligent subspecialty follow-up for
small mVSD might foster consequences akin to ‘cardiac
nondisease’ described years ago for innocent murmur
[23,24]. High clinical volume providers in this series
may have already concluded based on experience that
for the vast majority of small mVSD, the costs and
potential for adverse psychological impact associated
with routine subspecialty surveillance outweigh any
benefits.
Limitations
This study has the limitations associated with a retro-
spective cohort study. Several other factors may have
impacted follow up patterns on a case-by-case basis.
This type of investigation does not account for every-
thing that plays into pediatric cardiology provider deci-
sion to recommend follow up. Neither does it provide
timelines for follow up of small hemodynamically in-
significant mVSDs. Clinical scenarios for each patient
may be different, which influences pediatric cardiology
provider decisions.
Conclusion
Wide practice variation was observed in the surveillance
frequency for small and moderate sized mVSD within a
14-provider pediatric cardiology group, in the absence of
active medical or surgical management. Allowances
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exceptional cases, so an occasional mVSD will receive
follow up, but this investigation does not support a prac-
tice of regularly scheduled subspecialty surveillance.
Abbreviation
mVSD: muscular ventricular septal defect.
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